3 trends dragging medtechs: Supply chain constraints, inflation and hospital staffing shortages

Having weathered 18 months of COVID-19, industry hopes vision for a post-pandemic recovery is being impeded by three major challenges: supply chain, inflation and healthcare staffing shortages.

"One of the things that's giving a lot of medtech investors pause right is now is just a sheer number of macro issues to think through," from healthcare staffing to supply chain to inflation, Bob Hopkins, an analyst at Bank of America, noted on Boston Scientific's earnings call.